Inside Boeing's Deliveries Headline and Why the Numbers Are Not What They Look

The 2024 production pause following the door plug incident reset the entire 737 programme. Regulatory oversight intensified. Supply chain verification procedures were rebuilt. The production rate dropped from roughly 38 aircraft per month to the low teens for several quarters.

The 2025 trajectory was slow but steady recovery. By end-2025 the production rate had climbed back into the mid-20s on the 737 MAX, still below the FAA-approved cap of 38. The 787 programme continued a separate recovery arc, supply-chain constrained on cabin components and seat availability.

Defence and space, which was the quiet disaster of 2024 with billions of loss-making fixed-price contracts, has begun to show stabilisation. The Northrop-led competitive dynamic in defence aerospace has helped Boeing more than the headlines suggest.

The defence segment has been the margin drag for three years. Fixed-price development contracts on the KC-46 tanker, the T-7 trainer, and Starliner have all absorbed charges. The cumulative loss on those programmes exceeds $12 billion.

What has changed in the last six months is that the remaining charge tail has narrowed. Management has been explicit about the path to defence segment operating breakeven in 2026 and positive margin in 2027. The backlog supports the commentary, sitting at $62 billion of defence orders at quarter-end.

The BAE Systems Ascent announcement this week and the broader defence aerospace budget environment are constructive for Boeing. Defence aerospace has been on a long-term secular expansion.

At a normalised production rate of 38 per month on the 737 MAX and 10 per month on the 787, Boeing generates roughly $10 billion of annual free cash flow. The 2026 consensus of $6 billion reflects the gradual rate climb. The 2028 consensus reaches $12 billion, above the normalised run-rate because of catch-up working capital release.

The balance sheet carries net debt of roughly $47 billion. At normalised cash generation, the company can deleverage meaningfully over three to four years. The investment grade rating was reaffirmed in Q4 2025.

The stock at $215 trades at roughly 18x 2028 normalised earnings. That is defensible against the execution risk, and genuinely attractive if the production recovery holds.

Airbus continues to deliver more narrowbody aircraft than Boeing but has its own A320neo supply constraints. The competitive gap between the two has narrowed in the last 12 months rather than widened. That is a modest but real positive for Boeing.

The broader industrials group, GE Aerospace, RTX, Lockheed, all sit at elevated multiples reflecting the defence aerospace strength. Boeing's multiple discount reflects the execution risk. A clean 2026 delivery year would close a material portion of that discount.

Production rate normalisation is the primary driver. Every incremental aircraft above the current run-rate lands at high incremental margin because the fixed overhead is already absorbed.

Defence segment breakeven is the second driver. The inflection from negative to positive operating income in defence is roughly worth $2 billion of annualised improvement.

The third driver is services. The aftermarket services business has been running at 17% operating margin and growing at a mid-single-digit pace. It is the steady cash generator that anchors the model through the commercial aerospace cycle.